Management of patients with back pain in outpatient practice
Abstract
The authors studied the efficiency of drug therapy using the nonsteroidal anti-inflammatory drug (NSAID) meloxicam (Movalis) for nonspecific back pain and radiculopathy in the outpatient practice (without physio-, reflex, and manual therapies). Examination of 156 patients revealed a specific cause of back pain only in 6 (3.8%). Drug therapy using Movalis in 150 patients with acute, subacute, chronic nonspecific back pain at various sites or radiculopathy resulted in a considerable reduction in pain (as high as 1-3 VAS scores) and its complete regression in 97.3% of cases within 2-3 weeks of treatment. Movalis therapy was found to be well tolerated and caused a low frequency of side effects (1.7%) as mild gastrointenstinal disorders; Movalis used in combination with antiepileptic agents (pregabalin and gabapentin), myorelaxants (Midocalm) and Milgamma in some patents was ascertained to be also well tolerated.
About the Authors
O. N. Gerasimova
ZAO «Medical Services», Polyclinic Six
Russian Federation
Moscow
Russian Federation
Moscow
V. A. Parfenov
I.M. Sechenov First Moscow State Medical University
Russian Federation
Russian Federation
References
1. <div><p>Богачева Л.А., Снеткова Е.П. Боль в спине: клиника, патогенез, принципы ведения (опыт работы амбулаторного отделения боли в спине). Боль 2005;4:26-30.</p><p>Подчуфарова Е.В., Яхно Н.Н. Боли в спине и конечностях. В кн.: Болезни нервной системы. Рук-во для врачей. Под ред. Н.Н. Яхно. Т.2. М., 2005;306-31.</p><p>Подчуфарова Е.В., Яхно Н.Н. Боль в спине. М., 2010;368 с.</p><p>Bogduk N., McGuirk B. Medical management of acute and chronic low back pain. Amsterdam: Elsevier, 2002.</p><p>Van Tulder M., Becker A., Bekkering T. et al. European guidelines for the management of acute nonspecific low back pain in primary care. Eur Spine J 2006;15(Suppl. 2):169-91.</p><p>Shen F.H., Samartzis D., Andersson G.B. Nonsurgical management of acute and chronic low back pain. J Am Acad Orthop Surg 2006;8:477-87.</p><p>Dugan S.A. The role of exercise in the prevention and management of acute low back pain. Clin Occup Environ Med 2006;5:615-32.</p><p>Hayden J.A., van Tulder M.W., Malmivaara A. et al. Exercise therapy for treatment of nonspecific low back pain. Cochrane Database Syst Rev 2005;(3):CD000335.</p><p>Burton A.K., Balague F., Cardon G. et al., for the COST B13 Working Group on European Guidelines for Prevention in Low Back Pain. How to prevent low back pain. Best Pract Res Clin Rheumatol 2005;19:541-55.</p><p>Насонова В.А. Мелоксикам (мовалис) - селективный ингибитор ЦОГ-2 в клинической практике. Науч-практич ревматол 2000;4:16-21.</p><p>Degner F., Lanes S., van Ryn J. et al. Pharmacological and clinical profile meloхicam. Therapeutic roles of selective COХ-2 inhibitors. Vane J.R., Botting R.M. (Eds). London: William Harvey Press, 2001.</p><p>Singh G., Lanes S., Triadafilopoulos S. Risk of serious upper gastrointestinal and cardiovascular thromboembolic complications with meloxicam. Am J Med 2004;117:100-6.</p><p>Мазуров В.И. Применение мелоксикама (Мовалиса) у больных с ревматическими заболеваниями с сопутствующей ишемической болезнью сердца. Клин мед 2004;12:54-9.</p><p>Алексеев В.В., Подчуфарова Е.В. Применение мелоксикама (мовалиса) в лечении люмбоишиалгического синдрома. Боль 2004;4:49-53.</p><p>Гузева В.И., Гайгалас Л.М., Разумовский М.А. Мовалис в лечении острых дорсопатий. Журн неврол и психиатр 2004;5:58-9.</p><p>Филатова Е.Г., Кондриков А.В., Истомина О.И. Эффективность и переносимость лечения боли в нижней части спины с использованием инъекционной и таблетированной форм Мовалиса (мелоксикама). Фарматека 2008;3:23-5.</p><p>Шостак Н.А., Аксенова А.В., Шеметов Д.А. и др. Опыт применения Мовалиса при синдроме болей в нижней части спины (LBP). Тер арх 1999;11:50-2.</p><p>Colberg K., Hettich M., Sigmund R. et al. The efficacy and tolerability of an 8-day administration of intravenous and oral meloxicam: a comparison with intramuscular and oral diclofenac in patients with acute lumbago. German Meloxicam Ampoule Study Group. Curr Med Res Opin 1996;13:363-77.</p><p>Del Tacca M., Colucci R., Fornai M. et al. Efficacy and tolerability of meloxicam, COX-2 preferential nonsteroidal anti-inflammatory drug. Clin Drug Ivest 2002;22(12):799-818.</p><p>Dreiser R.L., Parc J.M., Velicitat P. et al. Oral meloxicam is effective in acute sciatica: two randomized, double-blind trials versus placebo or diclofenac. Inflammation Res 2001; 50(Suppl. 1):17-23.</p><p>Hawkey C. et al. Gastrointestinal tolerability of meloxicam compared diclofenac in osteoarthritis patients. International MELISSA Study Group. Meloxicam Large-scale International Study Safety Assessment. Rheumatol (Oxford) 1999;38:793-8.</p><p>Atttal N., Cruccu G., Baron R. EFNS guidelines on the pharmacological treatment of neuropathic pain: 2010 revision. Eur J Neurol 2010;17(9):1113-e88.</p><p>Chou R., Atlas S.J., Stanos S.P. Nonsurgical interventional therapies for low back pain: a review of the evidence for an American Pain Society clinical practice guideline. Spine 2009;34:1078-93.</p><p>Dworkin R.H., O'Connor A.B., Backonja M. et al. Pharmacologic management of neuropathic pain: evidence-based recommendations. Pain 2007;132:237-51.</p><p>Russo R.B. Diagnosis of low back pain: role of imaging studies. Clin Occup Environ Med 2006;5:571-89.</p><p>Герасимова О.Н., Парфенов В.А. Лечение острой неспецифической боли в спине в амбулаторной практике. Неврол нейропсихиатр психосом 2009;3-4:40-6.</p><p>Мелкумова К.А. Когнитивно-поведенческая психотерапия при лечении хронической боли. Неврол нейропсихиатр психосом 2010;1:9-13.</p><p>Подчуфарова Е.В. Дискогенная пояснично-крестцовая радикулопатия. Неврол нейропсихиатр психосом 2010;3:32-9.</p><p>Chou R., Huffman L.H. Nonpharmacologic therapies for acute and chronic low back pain: a review of the evidence for an American Pain Society/American College of Physicians clinical practice guideline. Ann Intern Med 2007;147:492-504.</p></div><br />
For citation:
Gerasimova O.N., Parfenov V.A. Management of patients with back pain in outpatient practice. Neurology, Neuropsychiatry, Psychosomatics. 2010;2(4):65-71. (In Russ.) https://doi.org/10.14412/2074-2711-2010-120
Views: 635
Email this article 